Replication study of 10 genes showing evidence for association with multiple sclerosis: Validation of TMEM39A, IL12B and CLBL genes

Multiple Sclerosis Journal

Volumn 18, Issue 7, 2012, Pages 959-965

  Varadé, Jezabel ^a   Comabella, Manuel ^b   Ortiz, Miguel A ^a   Arroyo, Rafael ^a   Fernández, Oscar ^c   Pinto Medel, M Jesús ^c   Fedetz, María ^d   Izquierdo, Guillermo ^e   Lucas, Miguel ^e   Gómez, Carlos López ^c   Rabasa, Antonio Catalá ^d   Alcina, Antonio ^d   Matesanz, Fuencisla ^d,e   Alloza, Iraide ^f   Antigüedad, Alfredo ^g   García Barcina, María ^g   Otaegui, David ^h   Olascoaga, Javier ⁱ   Saiz, Albert ^j   Blanco, Yolanda ^j   Montalbán, Xavier ^b   Vandenbroeck, Koen ^f,k   Urcelay, Elena ^a   more..

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^d INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^f UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^g HOSPITAL DE BASURTO   (Spain)

^h BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

ⁱ HOSPITAL DONOSTIA   (Spain)

^j BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^k BASQUE FOUNDATION FOR SCIENCE   (Spain)

more..

Author keywords

CBLB; IL12B; multiple sclerosis susceptibility; TMEM39A

Indexed keywords

ADULT; ANKN1 GENE; ARTICLE; AUTOIMMUNE DISEASE; CLBL GENE; CONTROLLED STUDY; CRN1 GENE; EPHA4 GENE; GENE; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GTF2B GENE; HUMAN; IL12B GENE; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PKN2 GENE; PTPRM GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TMEM39A GENE; YTHDF3 GENE;

EID: 84863199471     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511432741     Document Type: Article

References (36)

1. Handel AE, Handunnetthi L, Giovannoni G, Ebers GC and Ramagopalan SV. Genetic and environmental factors and the distribution of multiple sclerosis in Europe. Eur J Neurol. 2010; 17: 1210-4.
2. Jersild C, Ammitzboll T, Clausen J and Fog T. Association between HL-A antigens and measles antibody in multiple sclerosis. Lancet. 1973; 1: 151-2.
3. Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet. 2009; 41: 824-8.
4. Comabella M, Craig DW, Camina-Tato M, et al. Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PLoS One. 2008; 3: e3490.
5. International Multiple Sclerosis Genetics Consortium, IMSGC. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med. 2007; 357: 851-62.
6. Jakkula E, Leppa V, Sulonen AM, et al. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am J Hum Genet. 2010; 86: 285-91.
7. Sanna S, Pitzalis M, Zoledziewska M, et al. Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis. Nat Genet. 2010; 42: 495-7.
8. International Multiple Sclerosis Genetics Consortium, IMSGC. Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci. Hum Mol Genet. 2010; 19: 953-62.
9. Corrado L, Bergamaschi L, Barizzone N, et al. Association of the CBLB gene with multiple sclerosis: new evidence from a replication study in an Italian population. J Med Genet. 2011; 48: 210-1.
10. Tsunemi Y, Saeki H, Nakamura K, et al. Interleukin-12 p40 gene (IL12B) 3'-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J Dermatol Sci. 2002; 30: 161-6. (Pubitemid 36159027)
11. Cargill M, Schrodi SJ, Chang M, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet. 2007; 80: 273-90. (Pubitemid 46175676)
12. Wu Y, Lu Z, Chen Y, Xue F, Chen X and Zheng J. Replication of association between interleukin-23 receptor (IL-23R) and its ligand (IL-12B) polymorphisms and psoriasis in the Chinese Han population. Hum Immunol. 2010; 71: 1255-8.
13. Fisher SA, Tremelling M, Anderson CA, et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet. 2008; 40: 710-2. (Pubitemid 351748865)
14. Danoy P, Pryce K, Hadler J, et al. Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease. PLoS Genet. 2010; 6: e1001195.
15. Ramil E, Sanchez AJ, Gonzalez-Perez P, et al. The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain. Mult Scler. 2010; 16: 139-46.
16. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983; 13: 227-31. (Pubitemid 13158528)
17. Cavanillas ML, Fernandez O, Comabella M, et al. Replication of top markers of a genome-wide association study in multiple sclerosis in Spain. Genes Immun. 2011; 12: 110-5.
18. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature. 2009; 461: 747-53.
19. Aulchenko YS, Hoppenbrouwers IA, Ramagopalan SV, et al. Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat Genet. 2008; 40: 1402-3.
20. Booth DR, Heard RN, Stewart GJ, et al. Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis. Nat Genet. 2010; 42: 469-70; author reply 70-1.
21. Bergholdt R, Taxvig C, Eising S, Nerup J and Pociot F. CBLB variants in type 1 diabetes and their genetic interaction with CTLA4. J Leukoc Biol. 2005; 77: 579-85. (Pubitemid 40489534)
22. Payne F, Cooper JD, Walker NM, et al. Interaction analysis of the CBLB and CTLA4 genes in type 1 diabetes. J Leukoc Biol. 2007; 81: 581-3. (Pubitemid 46393534)
23. Filer C, Ho P, Smith RL, et al. Investigation of association of the IL12B and IL23R genes with psoriatic arthritis. Arthritis Rheum. 2008; 58: 3705-9.
24. Marquez A, Mendoza JL, Taxonera C, et al. IL23R and IL12B polymorphisms in Spanish IBD patients: no evidence of interaction. Inflamm Bowel Dis. 2008; 14: 1192-6.
25. Anderson CA, Boucher G, Lees CW, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet. 2011; 43: 246-52.
26. Gateva V, Sandling JK, Hom G, et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet. 2009; 41: 1228-33.
27. Capon F, Di Meglio P, Szaub J, et al. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet. 2007; 122: 201-6. (Pubitemid 47241785)
28. Begovich AB, Chang M, Caillier SJ, et al. The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosis. Hum Immunol. 2007; 68: 934-7. (Pubitemid 350235722)
29. Alloza I, Heggarty S, Goris A, et al. Interleukin-12 p40 polymorphism and susceptibility to multiple sclerosis. Ann Neurol. 2002; 52: 524-5.
30. van Veen T, Crusius JB, Schrijver HM, et al. Interleukin-12p40 genotype plays a role in the susceptibility to multiple sclerosis. Ann Neurol. 2001; 50: 275. (Pubitemid 32738159)
31. Walsh JP, Berry J, Liu S, et al. The clinical presentation of autoimmune thyroid disease in men is associated with IL12B genotype. Clin Endocrinol (Oxf). 2011; 74: 508-12.
32. International Multiple Sclerosis Genetics Consortium, IMSGC. IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci. Genes Immun. 2010; 11: 397-405.
33. Rossi S, Buttari F, Studer V, et al. The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. Mult Scler. 2011; 17: 281-8.
34. Storr M, Emmerdinger D, Diegelmann J, et al. The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease. PLoS One. 2010; 5: e9453.
35. Mkhikian H, Grigorian A, Li CF, et al. Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis. Nat Commun. 2011; 2: 334.
36. International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011 Aug 10;476(7359): 214-9.